|
| Press Releases |
|
 |
|
| Thursday, December 29, 2022 |
|
|
博安生物公布H股全球发售配发结果 |
| 由绿叶制药集团有限公司（股份代号：2186）分拆的山东博安生物技术股份有限公司（「博安生物」或「公司」）在今天公布全球发售配发结果，公司的H股将于12月30日于香港联合交易所有限公司（「香港联交所」）主板正式挂牌并开始交易。 more info >> |
|
|
博安生物公佈H股全球發售配發結果 |
| 由綠葉製藥集團有限公司（股份代號：2186）分拆的山东博安生物技术股份有限公司（「博安生物」或「公司」）在今天公佈全球發售配發結果，公司的H股將於12月30日於香港聯合交易所有限公司（「香港聯交所」）主板正式掛牌並開始交易。 more info >> |
|
|
Boan Biotech Announces Global Offering Allotment Results of H Shares |
| Shandong Boan Biotechnology Co., Ltd. ("Boan Biotech" or the "Company"), a spin-off of Luye Pharma Group Ltd. (stock code: 2186), announces the allotment results of its Global Offering today. more info >> |
|
| Monday, December 19, 2022 |
|
|
覆盖「研发-生产-商业化」的综合性生物制药公司 博安生物H股全球发售 |
| 由绿叶制药集团有限公司（股份代号：2186）分拆的山东博安生物技术股份有限公司（「博安生物」或「公司」）宣布全球发售及于香港联合交易所有限公司（「香港联交所」）主板上市之详情。 more info >> |
|
|
覆蓋「研發-生產-商業化」的綜合性生物製藥公司 博安生物H股全球發售 |
| 由綠葉製藥集團有限公司（股份代號：2186）分拆的山东博安生物技术股份有限公司（「博安生物」或「公司」）宣佈全球发售及於香港聯合交易所有限公司（「香港聯交所」）主板上市之詳情。 more info >> |
|
|
An Integrated Biopharmaceutical Company Covering "R&D- Production-Commercialization" Boan Biotech's Global Offering of H Shares |
| Shandong Boan Biotechnology Co., Ltd. ("Boan Biotech" or the "Company"), a spin-off of Luye Pharma Group Ltd. (stock code: 2186), announces details of its Global Offering and the listing on the Main Board of the Stock Exchange of Hong Kong ("SEHK"). more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
CIMC Group Revenue Reached RMB 156.611 Billion; Net Cash Flows from Operating Activities Nearly Doubled to RMB 18.514 Billion
Mar 26, 2026 22:31 HKT/SGT
|
|
|
中集集團2025年營收達1566億元 經營性現金流大幅增長近100%至185億元
Mar 26, 2026 22:31 HKT/SGT
|
|
|
中集集团2025年营收达1566亿元 经营性现金流大幅增长近100%至185亿元
Mar 26, 2026 22:31 HKT/SGT
|
|
|
Sharp Develops Long-Range Video Monitoring Technology
Mar 26, 2026 22:39 JST
|
|
|
中國生物製藥（1177.HK）：創新驅動高增長 管線與國際化打開長期空間
Mar 26, 2026 21:16 HKT/SGT
|
|
|
OKI and Hitachi Agree to Integrate Businesses Related to Automated Teller Machines (ATMs) and Other Automated Equipment
Mar 26, 2026 22:10 JST
|
|
|
Dynasty Fine Wines Announces 2025 Annual Results
Mar 26, 2026 20:51 HKT/SGT
|
|
|
Everest Medicines Enters into Asset Purchase Agreement for Etripamil Nasal Spray, Expanding Cardiovascular Footprint
Mar 26, 2026 20:40 HKT/SGT
|
|
|
王朝酒業公佈2025年全年業績
Mar 26, 2026 20:33 HKT/SGT
|
|
|
王朝酒业公布2025年全年业绩
Mar 26, 2026 20:22 HKT/SGT
|
|
|
HKTDC's response to Hong Kong's export figures for February
Mar 26, 2026 20:15: JST
|
|
|
Multi-Billion-Dollar Sports Brand U.S. Polo Assn. Launches Global Polo Shirt Campaign: An Icon Born from the Game
Mar 26, 2026 20:00: JST
|
|
|
IGG 'Doomsday: Last Survivors' Achieves Record-High Monthly Gross Billing of HK$130 Million
Mar 26, 2026 19:32 HKT/SGT
|
|
|
HKTDC's response to Hong Kong's export figures for February
Mar 26, 2026 19:15 HKT/SGT
|
|
|
Everest Medicines Enters into Asset Purchase Agreement for Etripamil Nasal Spray, Expanding Cardiovascular Footprint
Mar 26, 2026 19:12 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
